NZ515355A - Cyclocarbamate derivatives as progesterone receptor modulators - Google Patents
Cyclocarbamate derivatives as progesterone receptor modulatorsInfo
- Publication number
- NZ515355A NZ515355A NZ515355A NZ51535500A NZ515355A NZ 515355 A NZ515355 A NZ 515355A NZ 515355 A NZ515355 A NZ 515355A NZ 51535500 A NZ51535500 A NZ 51535500A NZ 515355 A NZ515355 A NZ 515355A
- Authority
- NZ
- New Zealand
- Prior art keywords
- alkyl
- alkynyl
- alkenyl
- optionally substituted
- ring
- Prior art date
Links
- 239000002379 progesterone receptor modulator Substances 0.000 title 1
- 229940095745 sex hormone and modulator of the genital system progesterone receptor modulator Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000000304 alkynyl group Chemical group 0.000 abstract 4
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 241000689227 Cora <basidiomycete fungus> Species 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18301299P | 1999-05-04 | 1999-05-04 | |
| US09/552,633 US6509334B1 (en) | 1999-05-04 | 2000-04-19 | Cyclocarbamate derivatives as progesterone receptor modulators |
| PCT/US2000/011822 WO2000066571A1 (en) | 1999-05-04 | 2000-05-01 | Cyclocarbamate derivatives as progesterone receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ515355A true NZ515355A (en) | 2004-02-27 |
Family
ID=26878647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ515355A NZ515355A (en) | 1999-05-04 | 2000-05-01 | Cyclocarbamate derivatives as progesterone receptor modulators |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1173426A1 (https=) |
| JP (1) | JP2002543193A (https=) |
| KR (1) | KR20010114250A (https=) |
| CN (1) | CN1145618C (https=) |
| AU (1) | AU766428B2 (https=) |
| BG (1) | BG106079A (https=) |
| BR (1) | BR0010213A (https=) |
| CA (1) | CA2371726A1 (https=) |
| CZ (1) | CZ20013951A3 (https=) |
| EA (1) | EA004512B1 (https=) |
| HU (1) | HUP0201609A3 (https=) |
| IL (1) | IL146280A0 (https=) |
| MX (1) | MXPA01011286A (https=) |
| NO (1) | NO321361B1 (https=) |
| NZ (1) | NZ515355A (https=) |
| PL (1) | PL351127A1 (https=) |
| SG (1) | SG114650A1 (https=) |
| SK (1) | SK15912001A3 (https=) |
| TR (1) | TR200103286T2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0510278A (pt) * | 2004-04-27 | 2007-10-30 | Wyeth Corp | método para produzir compostos, produto, e, composto |
| WO2006077821A1 (ja) * | 2005-01-19 | 2006-07-27 | Dainippon Sumitomo Pharma Co., Ltd. | アルドステロン受容体調節剤としての芳香族スルホン化合物 |
| US8314094B2 (en) | 2007-10-05 | 2012-11-20 | Msd K.K | Benzoxazinone derivative |
| CN111925353B (zh) * | 2020-08-31 | 2022-04-08 | 苏州大学附属第二医院 | 一种2-噻吩甲腈的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0510235A1 (en) * | 1991-04-26 | 1992-10-28 | Dong-A Pharm. Co., Ltd. | Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same |
| AU1694295A (en) * | 1994-01-28 | 1995-08-15 | Merck & Co., Inc. | Benzoxazinones as inhibitors of hiv reverse transcriptase |
| EP1043325B1 (en) * | 1994-12-22 | 2004-06-16 | Ligand Pharmaceuticals Incorporated | Steroid receptor modulator compounds and methods |
| DE69724630T2 (de) * | 1996-10-02 | 2004-07-29 | Bristol-Myers Squibb Pharma Co. | 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv-reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung |
-
2000
- 2000-05-01 PL PL00351127A patent/PL351127A1/xx not_active Application Discontinuation
- 2000-05-01 TR TR2001/03286T patent/TR200103286T2/xx unknown
- 2000-05-01 EP EP00928689A patent/EP1173426A1/en not_active Withdrawn
- 2000-05-01 JP JP2000615601A patent/JP2002543193A/ja active Pending
- 2000-05-01 CN CNB008071004A patent/CN1145618C/zh not_active Expired - Fee Related
- 2000-05-01 SG SG200400080A patent/SG114650A1/en unknown
- 2000-05-01 IL IL14628000A patent/IL146280A0/xx unknown
- 2000-05-01 AU AU46886/00A patent/AU766428B2/en not_active Ceased
- 2000-05-01 EA EA200101176A patent/EA004512B1/ru not_active IP Right Cessation
- 2000-05-01 CZ CZ20013951A patent/CZ20013951A3/cs unknown
- 2000-05-01 SK SK1591-2001A patent/SK15912001A3/sk unknown
- 2000-05-01 NZ NZ515355A patent/NZ515355A/xx unknown
- 2000-05-01 KR KR1020017013970A patent/KR20010114250A/ko not_active Ceased
- 2000-05-01 HU HU0201609A patent/HUP0201609A3/hu unknown
- 2000-05-01 BR BR0010213-0A patent/BR0010213A/pt not_active Application Discontinuation
- 2000-05-01 CA CA002371726A patent/CA2371726A1/en not_active Abandoned
- 2000-05-01 MX MXPA01011286A patent/MXPA01011286A/es unknown
-
2001
- 2001-11-02 BG BG106079A patent/BG106079A/xx unknown
- 2001-11-02 NO NO20015378A patent/NO321361B1/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TR200103286T2 (tr) | 2002-07-22 |
| EA200101176A1 (ru) | 2002-04-25 |
| HUP0201609A3 (en) | 2002-12-28 |
| AU766428B2 (en) | 2003-10-16 |
| PL351127A1 (en) | 2003-03-24 |
| BG106079A (en) | 2002-05-31 |
| KR20010114250A (ko) | 2001-12-31 |
| CN1349517A (zh) | 2002-05-15 |
| EA004512B1 (ru) | 2004-04-29 |
| JP2002543193A (ja) | 2002-12-17 |
| SK15912001A3 (sk) | 2002-06-04 |
| NO20015378D0 (no) | 2001-11-02 |
| MXPA01011286A (es) | 2003-07-14 |
| CN1145618C (zh) | 2004-04-14 |
| SG114650A1 (en) | 2005-09-28 |
| CA2371726A1 (en) | 2000-11-09 |
| CZ20013951A3 (cs) | 2002-05-15 |
| HUP0201609A2 (en) | 2002-08-28 |
| EP1173426A1 (en) | 2002-01-23 |
| AU4688600A (en) | 2000-11-17 |
| BR0010213A (pt) | 2002-02-19 |
| NO20015378L (no) | 2002-01-03 |
| IL146280A0 (en) | 2002-07-25 |
| NO321361B1 (no) | 2006-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA72917C2 (en) | Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor | |
| WO2000066564A8 (en) | Benzimidazolones and analogues and their use as progesterone receptor ligands | |
| DK1173433T3 (da) | Cyanopyrroler som progesteronreceptoragonister | |
| NO994452D0 (no) | Substituerte 4-arylmetylen-2-imino-2,3-dihydrotiazoler og derivater, og deres farmasöytiske anvendelse | |
| ATE194839T1 (de) | Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| AR035548A1 (es) | Compuestos organicos | |
| HUP0105079A2 (hu) | Indolszármazékok és felhasználásuk MCP-1 antagonistákként, eljárás a vegyületek előállítására és ezeket tartalmazó gyógyszerkészítmények | |
| AR035235A1 (es) | Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento | |
| BR0109855A (pt) | Derivados de 8-isoquinolinxantina e 8-quinolixantina como inibidores de pde 5 | |
| AR027402A1 (es) | Derivados de pirimidina. | |
| DE60107435D1 (de) | 2-adamantylethylamine und deren verwendung bei der behandlung von abnormalitäten in der glutamat transmission | |
| HUP9901096A2 (hu) | Indolszármazékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények | |
| BG106080A (en) | Cyclothiocarbamate derivatives as progesterone receptor modulators | |
| NZ528997A (en) | Sulfonamides | |
| PE20020253A1 (es) | Derivados de 3-azabiciclo[3.1.0]hexano como ligandos de receptores opiaceos | |
| DE69811556D1 (de) | Chinoline und Chinazoline Verbindungen und ihre therapeutische Anwendung | |
| ES2012648A6 (es) | Procedimiento para la preparacion de nuevos derivados de 1,4-benzoxazina y 1,4-benzotiazina. | |
| ES2152379T3 (es) | Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos. | |
| NZ515355A (en) | Cyclocarbamate derivatives as progesterone receptor modulators | |
| NO983100L (no) | 4,5-dihydronaft£1,2-C|isoksazoler og derivater derav med CNS-aktivitet | |
| HK1043991A1 (zh) | 作為黃體酮受體調節劑的喹唑啉酮及苯並噁嗪衍生物 | |
| GEP20043221B (en) | Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Pharmaceutical Composition Containing Them and Use Thereof for Treatment Progesterone-Related Maladies. | |
| UY26448A1 (es) | 1,2,3,4,5,6-hexahidro-2,6-metano -3 - benzazocinas sustituidas y su empleo como medicamentos. | |
| TWI265032B (en) | Pharmaceutically useful kits comprising progesterone receptor modulators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| ASS | Change of ownership |
Owner name: WYETH, US Free format text: OLD OWNER(S): WYETH; LIGAND PHARMACEUTICALS INC. |